A variety of molecular pathways linked active physical activity to lower NAFLD prevalence and prognosis, including AMP-activated protein kinase, glucose transporter 4 translocation, insulin signaling, modulating insulin action, cellular substrate flow, ectopic lipid and glycogen storage (27, 28). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.